Dr. Claudia Sehner, Boehringer Ingelheim - Qepler Summits And Conferences

Dr. Claudia Sehner

Senior Toxicologist
Boehringer Ingelheim
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience.

Dr. Claudia Sehner is Senior Toxicologist at Boehringer Ingelheim Pharma GmbH & Co. KG in Biberach (Germany). She is responsible for Occupational Exposure Limits (OELs) and Permitted Daily Exposure Limits (PDEs) setting and leads the respective committee at Boehringer Ingelheim. She is (co-) author of several scientific publications on health-based exposure limits.

Besides >15 years of experience in toxicological risk assessment/limit setting, Claudia Sehner has expertise as project toxicologist and in the fields of in vitro toxicology and toxicogenomics.

Claudia Sehner graduated with a Diploma in Chemistry from the Johannes Gutenberg University, Mainz, earned her doctorate at the Institute of Toxicology (Mainz), and is a board certified toxicologist (DGPT).

Related Sessions:

3rd Annual Highly Potent
APIs Summit 2023

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 22 Feb 2023
  • Virtual,
  • Pharma
WORKSHOP's Day: Friday, 24 February 2023
CASE STUDY: Health-based exposure limits (HBELs) for biotechnological products – when needed and how are they set?
  • HBELs (OELs and PDEs): Why are they needed?
  • Principles for the calculation of OELs and PDEs
  • Are OELs and PDEs required for biotechnological products/new modalities?
  • Particularities e.g., for protein- and RNA/DNA-based therapeutics
  • Considerations for implementation
View Details